These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 20471372
1. Insights into the mechanism of drug resistance: X-ray structure analysis of G48V/C95F tethered HIV-1 protease dimer/saquinavir complex. Prashar V, Bihani SC, Das A, Rao DR, Hosur MV. Biochem Biophys Res Commun; 2010 Jun 11; 396(4):1018-23. PubMed ID: 20471372 [Abstract] [Full Text] [Related]
2. Insight into analysis of interactions of saquinavir with HIV-1 protease in comparison between the wild-type and G48V and G48V/L90M mutants based on QM and QM/MM calculations. Saen-oon S, Aruksakunwong O, Wittayanarakul K, Sompornpisut P, Hannongbua S. J Mol Graph Model; 2007 Nov 11; 26(4):720-7. PubMed ID: 17543558 [Abstract] [Full Text] [Related]
3. Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance. Hong L, Zhang XC, Hartsuck JA, Tang J. Protein Sci; 2000 Oct 11; 9(10):1898-904. PubMed ID: 11106162 [Abstract] [Full Text] [Related]
4. A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance. Muzammil S, Ross P, Freire E. Biochemistry; 2003 Jan 28; 42(3):631-8. PubMed ID: 12534275 [Abstract] [Full Text] [Related]
5. Structural Basis of Why Nelfinavir-Resistant D30N Mutant of HIV-1 Protease Remains Susceptible to Saquinavir. Prashar V, Bihani SC, Ferrer JL, Hosur MV. Chem Biol Drug Des; 2015 Sep 28; 86(3):302-8. PubMed ID: 25487655 [Abstract] [Full Text] [Related]
6. A contribution to the drug resistance mechanism of darunavir, amprenavir, indinavir, and saquinavir complexes with HIV-1 protease due to flap mutation I50V: a systematic MM-PBSA and thermodynamic integration study. Leonis G, Steinbrecher T, Papadopoulos MG. J Chem Inf Model; 2013 Aug 26; 53(8):2141-53. PubMed ID: 23834142 [Abstract] [Full Text] [Related]
7. Insights into a mutation-assisted lateral drug escape mechanism from the HIV-1 protease active site. Sadiq SK, Wan S, Coveney PV. Biochemistry; 2007 Dec 25; 46(51):14865-77. PubMed ID: 18052195 [Abstract] [Full Text] [Related]
14. Structure of a G48H mutant of HIV-1 protease explains how glycine-48 replacements produce mutants resistant to inhibitor drugs. Hong L, Zhang XJ, Foundling S, Hartsuck JA, Tang J. FEBS Lett; 1997 Dec 22; 420(1):11-6. PubMed ID: 9450540 [Abstract] [Full Text] [Related]
15. A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV-1 protease. Vega S, Kang LW, Velazquez-Campoy A, Kiso Y, Amzel LM, Freire E. Proteins; 2004 May 15; 55(3):594-602. PubMed ID: 15103623 [Abstract] [Full Text] [Related]
16. Insights into the mechanism of drug resistance: X-ray structure analysis of multi-drug resistant HIV-1 protease ritonavir complex. Liu Z, Yedidi RS, Wang Y, Dewdney TG, Reiter SJ, Brunzelle JS, Kovari IA, Kovari LC. Biochem Biophys Res Commun; 2013 Feb 08; 431(2):232-8. PubMed ID: 23313846 [Abstract] [Full Text] [Related]
18. Structural and dynamical properties of different protonated states of mutant HIV-1 protease complexed with the saquinavir inhibitor studied by molecular dynamics simulations. Aruksakunwong O, Wittayanarakul K, Sompornpisut P, Sanghiran V, Parasuk V, Hannongbua S. J Mol Graph Model; 2006 Nov 08; 25(3):324-32. PubMed ID: 16504560 [Abstract] [Full Text] [Related]